TTD | Drug: D0J6XO

Drug General Information
Drug ID	D0J6XO
Former ID	DNC002333
Drug Name	A-331440
Drug Type	Small molecular drug
Indication	Obesity [ICD9: 278; ICD10:E66]		Investigative	[540626]
Company	Abbott
Structure		Download 2D MOL 3D MOL
Formula	C22H27N3O
InChI	InChI=1S/C22H27N3O/c1-24(2)21-12-14-25(17-21)13-3-15-26-22-10-8-20(9-11-22)19-6-4-18(16-23)5-7-19/h4-11,21H,3,12-15,17H2,1-2H3/t21-/m1/s1
InChIKey	FXIPXWLVYIHFEP-OAQYLSRUSA-N
PubChem Compound ID	9884746
PubChem Substance ID	14851916, 24171612, 45631687, 75067907, 103322883, 104098428, 139979942, 163642313, 172918048, 178100849, 198956291, 202535704, 231069775, 248964671
Target and Pathway
Target(s)	Histamine H3 receptor	Target Info	Antagonist	[536039]
KEGG Pathway	Neuroactive ligand-receptor interaction
Reactome	Histamine receptors
Reactome	G alpha (i) signalling events
WikiPathways	Monoamine Transport
	GPCRs, Class A Rhodopsin-like
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 540626	(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4023).
Ref 536039	The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov. 2005 Feb;4(2):107-20.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information